First real-world UK data shows Pfizer-BioNTech vaccine provides high levels of protection from the first dose

Data analysed by Public Health England show Pfizer-BioNTech vaccine provides high levels of protection against infection/symptomatic disease from the 1st dose. Data suggest one dose of the vaccine reduces the risk of infection by more than 70%, rising to 85% after the second dose

Source:

Public Health England